Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK Experience
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK Experience
Authors
Keywords
-
Journal
Journal of Crohns & Colitis
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-04-10
DOI
10.1093/ecco-jcc/jjaa075
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Real-World Experience with Tofacitinib in IBD at a Tertiary Center
- (2019) Roni Weisshof et al. DIGESTIVE DISEASES AND SCIENCES
- Unmet Medical Needs in Ulcerative Colitis: An Expert Group Consensus
- (2019) Silvio Danese et al. DIGESTIVE DISEASES
- Tofacitinib Treatment is Associated with Modest and Reversible Increases in Serum Lipids in Patients with Ulcerative Colitis
- (2019) Bruce E. Sands et al. Clinical Gastroenterology and Hepatology
- An economic evaluation of tofacitinib for the treatment of moderately-to-severely active ulcerative colitis: modeling the cost of treatment strategies in the United States
- (2019) Sandra Milev et al. JOURNAL OF MEDICAL ECONOMICS
- JAK selectivity for inflammatory bowel disease treatment: does it clinically matter?
- (2019) Silvio Danese et al. GUT
- Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
- (2019) Nicholas A Kennedy et al. Lancet Gastroenterology & Hepatology
- Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme
- (2019) William J. Sandborn et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open
- (2019) Bruce E. Sands et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis
- (2019) Loriane Lair-Mehiri et al. DIGESTIVE AND LIVER DISEASE
- Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis
- (2018) Stephen Hanauer et al. Clinical Gastroenterology and Hepatology
- Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials
- (2018) William J. Sandborn et al. Clinical Gastroenterology and Hepatology
- Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials
- (2017) Julian Panés et al. GUT
- Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors
- (2017) Dafna Gladman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
- (2017) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current best practice for disease activity assessment in IBD
- (2016) Alissa J. Walsh et al. Nature Reviews Gastroenterology & Hepatology
- Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist
- (2016) Christina Charles-Schoeman et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Factors Associated With Poor Outcomes in Adults With Newly Diagnosed Ulcerative Colitis
- (2015) Walter Reinisch et al. Clinical Gastroenterology and Hepatology
- Potential Mechanisms Leading to the Abnormal Lipid Profile in Patients With Rheumatoid Arthritis Versus Healthy Volunteers and Reversal by Tofacitinib
- (2015) Christina Charles-Schoeman et al. Arthritis & Rheumatology
- A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease
- (2014) William J. Sandborn et al. Clinical Gastroenterology and Hepatology
- Janus Kinase Inhibition with Tofacitinib: Changing the Face of Inflammatory Bowel Disease Treatment
- (2013) Lucine Vuitton et al. CURRENT DRUG TARGETS
- Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
- (2012) Roy Fleischmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)
- (2011) Simon P L Travis et al. GUT
- Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
- (2011) W. Reinisch et al. GUT
- Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
- (2009) William J. Sandborn et al. GASTROENTEROLOGY
- Definition of Phenotypic Characteristics of Childhood-Onset Inflammatory Bowel Disease
- (2008) Johan Van Limbergen et al. GASTROENTEROLOGY
- Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis
- (2008) James D. Lewis et al. INFLAMMATORY BOWEL DISEASES
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support
- (2008) Paul A. Harris et al. JOURNAL OF BIOMEDICAL INFORMATICS
- Long-term outcome after infliximab for refractory ulcerative colitis
- (2008) Marc Ferrante et al. Journal of Crohns & Colitis
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More